Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2026-02-04 00:00:00 ET · period of report 2026-01-26 · accession 0000905148-26-000495 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-04 | 2026-01-26+ | RIGL | RODRIGUEZ RAUL R | CEO, Pres, Dir | F - Tax | $36.84 | -84.7K | 245.2K | -26% | -$3.12M |
| DM | 2026-02-04 | 2026-01-26 | RIGL | RODRIGUEZ RAUL R | CEO, Pres, Dir | M - OptEx | $27.40 | +80.0K | 280.5K | +40% | +$2.19M |
| DM | 2026-02-04 | 2026-01-26 | RIGL | RODRIGUEZ RAUL R | CEO, Pres, Dir | M - OptEx | $0.00 | -80.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-02 | F | D | 14,110 | $36.01 | 235,709 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-26 | F | D | 35,424 | $37.00 | 249,819 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-26 | M | A | 40,000 | $27.40 | 285,243 | D | — | — | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. |
| 4 | Common | Common Stock | 2026-01-26 | M | A | 40,000 | $27.40 | 280,454 | D | — | — | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F2) Includes 1,000 shares acquired under the Issuer's stock purchase plan. |
| 5 | Common | Common Stock | 2026-01-26 | F | D | 35,211 | $37.00 | 245,243 | D | — | — | |
| 6 | Derivative | Employee Stock Option (right to buy) | 2026-01-26 | M | D | 40,000 | $0.00 | 0 | D | $27.40 · — to 2026-01-26 | 40,000 Common Stock | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F3) The shares vested monthly over two (2) years from January 1, 2016. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2026-01-26 | M | D | 40,000 | $0.00 | 0 | D | $27.40 · 2017-04-19 to 2026-01-26 | 40,000 Common Stock | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. |